Aβ(8-20) Fragment as an Anti-Fibrillogenic and Neuroprotective Agent: Advancing toward Efficient Alzheimer’s Disease Treatment

[Image: see text] Alzheimer’s disease (AD) is the most common cause of dementia, characterized by a spectrum of symptoms associated with memory loss and cognitive decline with deleterious consequences in everyday life. The lack of specific drugs for the treatment and/or prevention of this pathology...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimbone, Stefania, Giuffrida, Maria Laura, Sabatino, Giuseppina, Di Natale, Giuseppe, Tosto, Rita, Consoli, Grazia M. L., Milardi, Danilo, Pappalardo, Giuseppe, Sciacca, Michele F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020970/
https://www.ncbi.nlm.nih.gov/pubmed/36857606
http://dx.doi.org/10.1021/acschemneuro.2c00720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020970/
https://www.ncbi.nlm.nih.gov/pubmed/36857606
http://dx.doi.org/10.1021/acschemneuro.2c00720

Ejemplares similares